Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 12;7:1833. doi: 10.1038/s41598-017-01862-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Comparison of injecting career duration of 20 years (red) and 10 years (blue) for the ec-network on the effect of different treatment rates on equilibrium (A) prevalence of HCV infection; incidence per year of (B) chronic infection (including arising from reinfection), (C) cured by successful treatment, (D) reinfection; and (E) life-years gained, for treatment rates varied from 0 to 30% per year. For the shorter injecting career duration, the number of individuals entering and leaving is twice as high (100/year) for a system of the same size (1000 individuals). The infection rate has been fitted to obtain 43% prevalence of chronic infection in the absence of treatment (α is 1.3 times the one for 20 years). For an infection duration of 10 years (close to the assumption in ref. 22), treatment is much less effective in reducing prevalence.